Taiko Pharmaceutical Co., Ltd.'s market cap is currently ¥15.17B. The company's EPS TTM is ¥-0.26; its P/E ratio is 36.82; Taiko Pharmaceutical Co., Ltd. is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 22
Dec 21
Dec 20
Dec 19
Currency in JPY
Taiko Pharmaceutical Co., Ltd. Earnings and Revenue History
